Document is current
Any future updates will be listed below
-
Authors
Wagner, Robert
Buettner, Janine
Heni, Martin
Fritsche, Louise
Kullmann, Stephanie
Wagmüller, Moritz
Peter, Andreas
Preissl, Hubert https://orcid.org/0000-0002-8859-4661
Machann, Jürgen
Jumpertz von Schwartzenberg, Reiner
Birkenfeld, Andreas L.
Pape, Ulrich-Frank
van Hall, Gerrit
Plomgaard, Peter
Häring, Hans-Ulrich
Fritsche, Andreas
Thompson, Kelsey N.
Klein, Reinhild
Stefan, Norbert
-
Funding
Funding for this research was provided by:
Universitätsklinikum Düsseldorf. Anstalt öffentlichen Rechts
- License Information
-
More Information
Article History
Received: 9 June 2024
Accepted: 13 November 2024
First Online: 26 November 2024
Declarations
:
: The study was approved by the Ethical Committee of the Medical Faculty of the University of Tübingen, Germany (project number 359/2012BO1). All participants provided written informed consent.
: All authors have reviewed and approved the manuscript for submission.
: RW reports lecture fees from NovoNordisk, Eli Lilly, Boehringer-Ingelheim and Sanofi, and travel grants from Eli Lilly, Sanofi and NovoNordisk. He served on the advisory board of Akcea Therapeutics, Daiichi Sankyo, Sanofi and NovoNordisk.Outside of the current work, MH reports research grants from Boehringer Ingelheim and Sanofi to the University Hospital of Tübingen, participation in advisory board for Boehringer Ingelheim and Sanofi and lecture fees from Amryt, Bayer, Sanofi, Eli Lilly, Novo Nordisk and Boehringer Ingelheim.
